Ensho Therapeutics
Operator of a biopharmaceutical company intended to develop oral therapies for patients with inflammatory diseases. The company offers oral, selective small molecule inhibitors of lymphocyte homing in...
Valuation
$0
Share Price
N/A
Total Raised
$27.9M
Last Round
N/A